Mingjia Tan
- Molecular Biology top 5%
- Oncology top 5%
- Cancer Research top 5%
- Cell Biology top 5%
- Immunology top 10%
- Co-authors
- Yi SunKun‐Liang GuanYixin WangManju SwaroopJie XuXiufang XiongYongchao ZhaoLarry W. Oberley
- Topics
- Ubiquitin and proteasome pathways (31 papers)Cancer-related Molecular Pathways (18 papers)Cancer-related gene regulation (8 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryJournal of Clinical Investigation
- Partner nations
- United StatesChinaSpain
In The Last Decade
Mingjia Tan
44 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 101
- Molecular Biology 1.9k
- Oncology 760
- Cancer Research 434
- Cell Biology 352
- Immunology 312
Countries citing papers authored by Mingjia Tan
This map shows the geographic impact of Mingjia Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingjia Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingjia Tan more than expected).
Fields of papers citing papers by Mingjia Tan
This network shows the impact of papers produced by Mingjia Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingjia Tan. The network helps show where Mingjia Tan may publish in the future.
Co-authorship network of co-authors of Mingjia Tan
This figure shows the co-authorship network connecting the top 25 collaborators of Mingjia Tan. A scholar is included among the top collaborators of Mingjia Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingjia Tan. Mingjia Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 8 | |
| 3 | 18 | |
| 4 | 61 | |
| 5 | 76 | |
| 6 | 36 | |
| 7 | 13 | |
| 8 | 20 | |
| 9 | 60 | |
| 10 | 106 | |
| 11 | 44 | |
| 12 | 8 | |
| 13 | 34 | |
| 14 | 80 | |
| 15 | 33 | |
| 16 | 16 | |
| 17 | 68 | |
| 18 | 120 | |
| 19 | 83 | |
| 20 | 204 |
About Mingjia Tan
Mingjia Tan is a scholar working on Oncology, Molecular Biology and Cancer Research, having authored 46 papers that have together received 2.5k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (31 papers), Cancer-related Molecular Pathways (18 papers) and Cancer-related gene regulation (8 papers). The work is most often cited by research in Cancer Research (434 citations), Molecular Biology (1.9k citations) and Oncology (760 citations). Mingjia Tan has collaborated with scholars based in United States, China and Spain. Frequent co-authors include Yi Sun, Kun‐Liang Guan, Yixin Wang, Manju Swaroop, Jie Xu, Xiufang Xiong, Yongchao Zhao, Larry W. Oberley, Hua Li and Shijun Li. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.